BlackRock Group’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
KKRC
BFA
BA
GGHC
BlackRock Group's AMED Position: Q4 2016 in Review
BlackRock Group increased its Amedisys (AMED) stake by 29% in Q4 2016, buying an estimated $7.21M and bringing the position to 748,415 shares worth $31.9M. The position accounts for 0.02% of the portfolio, ranked #695.
BlackRock Group first reported a position in AMED in Q2 2013 and has held it in 15 quarters since. 159 funds tracked by Wall St. Rank hold AMED as of Q4 2016.
- BlackRock Group held 748,415 shares of Amedisys worth $31.9M as of Q4 2016.
- BlackRock Group bought 169,474 Amedisys shares in Q4 2016, an estimated $7.21M.
- Amedisys made up 0.02% of BlackRock Group's portfolio in Q4 2016, its #695 holding.
- BlackRock Group first reported a position in Amedisys in Q2 2013 and has held it in 15 quarters since.
- 159 funds tracked by Wall St. Rank held Amedisys as of Q4 2016.
Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.